Skip to Content
Merck
CN

M8168

4-Methylumbelliferyl phosphate disodium salt

phosphatase substrate, ≥98% (TLC), powder

Synonym(s):

4-MUP, Disodium 4-methylumbelliferyl phosphate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C10H7Na2O6P
CAS Number:
22919-26-2
Molecular Weight:
300.11
NACRES:
NA.32
PubChem Substance ID:
24897230
UNSPSC Code:
12352204
EC Number:
245-325-0
MDL number:
MFCD00037614

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

4-Methylumbelliferyl phosphate disodium salt, phosphatase substrate

InChI key

WUUDJQVNZPEPKN-UHFFFAOYSA-L

InChI

1S/C10H9O6P.2Na/c1-6-4-10(11)15-9-5-7(2-3-8(6)9)16-17(12,13)14;;/h2-5H,1H3,(H2,12,13,14);;/q;2*+1/p-2

SMILES string

[Na+].[Na+].CC1=CC(=O)Oc2cc(OP([O-])([O-])=O)ccc12

description

phosphatase substrate

assay

≥98% (TLC)

form

powder

solubility

water: 50 mg/mL, clear, colorless

fluorescence

λex 319 nm; λem 384 nm (pH 9.0)
λex 360 nm; λem 449 nm (Reaction product)

storage temp.

−20°C

Quality Level

300

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Fluorogenic substrate for phosphatases.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000507890
0000507890
0000432629
0000432629
0000375479

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Giulia Pavani et al.
Nature communications, 11(1), 3778-3778 (2020-07-31)
Targeted genome editing has a great therapeutic potential to treat disorders that require protein replacement therapy. To develop a platform independent of specific patient mutations, therapeutic transgenes can be inserted in a safe and highly transcribed locus to maximize protein
David D Lo et al.
BMC biotechnology, 12, 7-7 (2012-03-15)
Mucosal immune surveillance is thought to be largely achieved through uptake by specialized epithelial M cells. We recently identified Claudin 4 as an M cell target receptor and developed a Claudin 4 targeting peptide (CPE) that can mediate uptake of
Erica Silberstein et al.
PloS one, 13(4), e0195879-e0195879 (2018-04-20)
Chagas disease, caused by the intracellular protozoan Trypanosoma cruzi, affects 8-10 million people worldwide and represents a major public health challenge. There is no effective treatment or vaccine to control the disease that is characterized by a mild acute phase
Ameirika et al.
Toxicon : official journal of the International Society on Toxinology, 133, 153-161 (2017-05-10)
Hydra actinoporin-like toxin-1 (HALT-1) is a 20.8 kDa pore-forming toxin isolated from Hydra magnipapillata. HALT-1 shares structural similarity with actinoporins, a family that is well known for its haemolytic and cytolytic activity. However, the precise pore-forming mechanism of HALT-1 remains an
Lucia A de Oliveira Fraga et al.
BMC immunology, 11, 56-56 (2010-11-17)
During the pre-patent stage of infection, juvenile Schistosoma blood flukes co-opt signals from the adaptive immune system to facilitate parasite development, but the types of responses that are induced at this early stage of infection, and the parasite antigens they
View All Related Papers

Related Content

Product Information Sheet - M8168

Product Information Sheet

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service